{
    "ticker": "SNTG",
    "name": "Sientra, Inc.",
    "description": "Sientra, Inc. is a medical aesthetics company that specializes in breast implants and other aesthetic products for plastic surgeons and their patients. Founded in 2008, Sientra's mission is to provide innovative and safe options for breast augmentation and reconstruction, primarily focusing on the needs of women. The company offers a range of silicone gel breast implants, which are known for their quality and performance. Sientra also emphasizes patient safety and satisfaction, providing comprehensive educational resources and support. The company is committed to advancing its product offerings through research and development, ensuring that their implants meet the highest standards of safety and effectiveness. Sientra's strong focus on innovation is reflected in their unique designs and manufacturing processes, aiming to enhance the patient experience and improve surgical outcomes. With a dedicated sales force and a robust marketing strategy, Sientra seeks to expand its presence in the growing medical aesthetics market, catering not only to breast surgery but also exploring opportunities in other aesthetic procedures. The company strives to empower women by providing them with choices that align with their personal aesthetic goals.",
    "industry": [
        "Medical Devices",
        "Aesthetics"
    ],
    "headquarters": "Santa Barbara, California, USA",
    "founded": "2008",
    "website": "https://www.sientra.com",
    "ceo": "Jeffrey M. Nugent",
    "social_media": {
        "twitter": "https://twitter.com/sientra",
        "linkedin": "https://www.linkedin.com/company/sientra/"
    },
    "investor_relations": "https://investors.sientra.com",
    "key_executives": [
        {
            "name": "Jeffrey M. Nugent",
            "position": "CEO"
        },
        {
            "name": "Chad M. McClain",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Breast Implants",
            "products": [
                "Silicone Gel Breast Implants",
                "Breast Reconstruction Products"
            ]
        },
        {
            "category": "Aesthetic Products",
            "products": [
                "Body Contouring Products"
            ]
        }
    ],
    "seo": {
        "meta_title": "Sientra, Inc. | Innovative Breast Implants and Aesthetic Solutions",
        "meta_description": "Explore Sientra, Inc., a leader in breast implants and aesthetic products. Discover their commitment to innovation and patient safety in the medical aesthetics industry.",
        "keywords": [
            "Sientra",
            "Breast Implants",
            "Medical Aesthetics",
            "Silicone Implants",
            "Cosmetic Surgery",
            "Aesthetic Products"
        ]
    },
    "faq": [
        {
            "question": "What does Sientra specialize in?",
            "answer": "Sientra specializes in breast implants and aesthetic products for plastic surgeons."
        },
        {
            "question": "Who is the CEO of Sientra?",
            "answer": "Jeffrey M. Nugent is the CEO of Sientra, Inc."
        },
        {
            "question": "Where is Sientra headquartered?",
            "answer": "Sientra is headquartered in Santa Barbara, California, USA."
        },
        {
            "question": "What are Sientra's main products?",
            "answer": "Sientra's main products include silicone gel breast implants and breast reconstruction products."
        },
        {
            "question": "When was Sientra founded?",
            "answer": "Sientra was founded in 2008."
        }
    ],
    "competitors": [
        "MGTI",
        "HCA",
        "ALGN",
        "TEVA"
    ],
    "related_stocks": [
        "BAX",
        "MDT",
        "SYK",
        "ZBH"
    ]
}